Cost-effectiveness of ivosidenib in patients with previously treated isocitrate dehydrogenase 1 (IDH1)-mutant cholangiocarcinoma: An Italian perspective

Hepatobiliary and Pancreatic Diseases International · Published 2026-01-02 · DOI 10.1016/j.hbpd.2025.12.018

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.hbpd.2025.12.018

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles